PUBLICATION REGISTRY

Go to research.

Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.

Publikationer som ChEBI hänvisar till för 10058-F4. Visa hela publikationsregistret

A publication hit is not a conclusion. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.

Publications in the selection

10 hits

Bibliografisk träff 2020-03-12

PI3K Abrogation Using Pan-PI3K Inhibitor BKM120 Gives Rise to a Significant Anticancer Effect on AML-Derived KG-1 Cells by Inducing Apoptosis and G2/M Arrest

Sadeghi S, Esmaeili S, Pourbagheri-Sigaroodi A, Safaroghli-Azar A, Bashash D.

Turk J Haematol · research-article; journal article · DOI 10.4274/tjh.galenos.2020.2019.0440

Bibliografisk träff 2019-11-23

C-Myc inhibition sensitizes pre-B ALL cells to the anti-tumor effect of vincristine by altering apoptosis and autophagy: Proposing a probable mechanism of action for 10058-F4.

Sheikh-Zeineddini N, Safaroghli-Azar A, Salari S, Bashash D.

Eur J Pharmacol · journal article · DOI 10.1016/j.ejphar.2019.172821

Bibliografisk träff 2019-04-07

Suppression of c-Myc using 10058-F4 exerts caspase-3-dependent apoptosis and intensifies the antileukemic effect of vincristine in pre-B acute lymphoblastic leukemia cells.

Sheikh-Zeineddini N, Bashash D, Safaroghli-Azar A, Riyahi N, Shabestari RM, Janzamin E, Safa M.

J Cell Biochem · research support, non-u.s. gov't; journal article · DOI 10.1002/jcb.28675

Bibliografisk träff 2019-01-09

Small molecule inhibitor of c-Myc 10058-F4 inhibits proliferation and induces apoptosis in acute leukemia cells, irrespective of PTEN status.

Bashash D, Sayyadi M, Safaroghli-Azar A, Sheikh-Zeineddini N, Riyahi N, Momeny M.

Int J Biochem Cell Biol · research support, non-u.s. gov't; journal article · DOI 10.1016/j.biocel.2019.01.005

Bibliografisk träff 2018-06-01

The inhibition of c-MYC transcription factor modulates the expression of glycolytic and glutaminolytic enzymes in FaDu hypopharyngeal carcinoma cells.

Kleszcz R, Paluszczak J, Krajka-Kuźniak V, Baer-Dubowska W.

Adv Clin Exp Med · journal article · DOI 10.17219/acem/68979

Bibliografisk träff 2015-06-01

Inhibition of c-Myc by 10058-F4 induces growth arrest and chemosensitivity in pancreatic ductal adenocarcinoma.

Zhang M, Fan HY, Li SC.

Biomed Pharmacother · journal article · DOI 10.1016/j.biopha.2015.05.019

Bibliografisk träff 2014-06-24

10058-F4, a c-Myc inhibitor, markedly increases valproic acid-induced cell death in Jurkat and CCRF-CEM T-lymphoblastic leukemia cells.

Mu Q, Ma Q, Lu S, Zhang T, Yu M, Huang X, Chen J, Jin J.

Oncol Lett · research-article; journal article · DOI 10.3892/ol.2014.2277

Bibliografisk träff 2008-05-29

Efficacy, pharmacokinetics, tisssue distribution, and metabolism of the Myc-Max disruptor, 10058-F4 [Z,E]-5-[4-ethylbenzylidine]-2-thioxothiazolidin-4-one, in mice.

Guo J, Parise RA, Joseph E, Egorin MJ, Lazo JS, Prochownik EV, Eiseman JL.

Cancer Chemother Pharmacol · research-article; research support, u.s. gov't, non-p.h.s.; journal article; research support, n.i.h., extramural · DOI 10.1007/s00280-008-0774-y

Bibliografisk träff 2007-02-01

Small-molecule c-Myc inhibitor, 10058-F4, inhibits proliferation, downregulates human telomerase reverse transcriptase and enhances chemosensitivity in human hepatocellular carcinoma cells.

Lin CP, Liu JD, Chow JM, Liu CR, Liu HE.

Anticancer Drugs · journal article · DOI 10.1097/cad.0b013e3280109424

Bibliografisk träff 2006-11-01

A small-molecule c-Myc inhibitor, 10058-F4, induces cell-cycle arrest, apoptosis, and myeloid differentiation of human acute myeloid leukemia.

Huang MJ, Cheng YC, Liu CR, Lin S, Liu HE.

Exp Hematol · research support, non-u.s. gov't; journal article · DOI 10.1016/j.exphem.2006.06.019